Naomi Fried

Naomi Fried is the Director at Wavely Diagnostics. Prior to Wavely, they were the CEO and Founder of Health Innovation Strategies, a consulting firm that provided digital health strategy and innovation infrastructure management consulting services to healthcare clients including pharma, providers, and startups. Naomi has also held positions at various other companies such as Ambit Health Ventures, ResApp Health, and nQ Medical Inc.

Throughout their career, Naomi has provided strategic guidance and advice on a range of topics related to healthcare innovation and digital health. Naomi has helped develop strategic plans for robust enterprise innovation programs, advised on emerging trends in the pharmaceutical industry, and created strategic frameworks for building competencies and capabilities in digital health.

Naomi’s experience and expertise in digital health make their well-suited for their current role at Wavely Diagnostics. In this role, they are responsible for leading the company’s digital transformation efforts and ensuring that Wavely’s products and services are designed with the latest digital technologies in mind.

Naomi Fried received their B.S. in Chemistry from University of California, Berkeley. Naomi went on to earn their Ph.D. in Materials Science Engineering from Massachusetts Institute of Technology.